Skip to main content
♕ The Globe and Mail Trade Off
Canada's free stock market contest is live! Test your investing skills for a chance to win $5,000.Enter Now!Enter Now!
➜

Cronos Group Inc(CRON-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low2.50
Day High2.59
Open:2.55
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Cronos Group Inc

Select a category then submit the form to load news
Tipranks
Cronos Group Posts Record 2025 Revenue and Eyes European Cannabis Expansion
GlobeNewswire
Cronos Group Reports 2025 Fourth Quarter and Full-Year Results
GlobeNewswire
Cronos Launches New All-in-One Vape, Spinach PUFFERZ™
Newswire.ca
Format Innovation Reshapes a $438B Functional Market
GlobeNewswire
Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026
GlobeNewswire
Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy
Zacks Investment Research
What's Next for Tilray Brands After Posting Record Q2 Revenues?
What's Next for Tilray Brands After Posting Record Q2 Revenues?
Motley Fool
Think You Know Altria? Here's 1 Little-Known Fact You Can't Overlook.
Motley Fool
Could Altria Help You Become a Millionaire?
Zacks Investment Research
Riding the Marijuana Reclassification Wave: 3 Stocks to Watch in 2026
Riding the Marijuana Reclassification Wave: 3 Stocks to Watch in 2026
Motley Fool
Has Altria Stock Been Good For Investors?
Motley Fool
Stock Market Today, Dec. 16: Tilray Brands Surges 27.5% After Trump Signals Possible Marijuana Reclassification
Tipranks
Trump expected to sign EO to reclassify marijuana as soon as Monday, CNBC says
Zacks Investment Research
Cronos Group Plans Strategic Europe Expansion: How to Play the Stock?
Cronos Group Plans Strategic Europe Expansion: How to Play the Stock?
Tipranks
Cronos Group Announces Acquisition of CanAdelaar B.V.
GlobeNewswire
Cronos to enter the Netherlands with acquisition of Europe’s largest adult-use cannabis company
Tipranks
Cronos Group’s Q3 2025 Earnings: Record Growth Amid Challenges
Tipranks
Cronos Group Achieves Record Revenue and Profit in Q3 2025
Tipranks
Cronos Group Achieves Record Q3 2025 Results, Strengthens Global Position
GlobeNewswire
Cronos Group Reports 2025 Third Quarter Results
GlobeNewswire
Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025
Motley Fool
Could Buying Altria Today Set You Up for Life?
Motley Fool
1 Major Reason Cannabis Stocks Surged This Week
Zacks Investment Research
Cannabis Stock CRON Trades Near 52-Week High: How to Play
Cannabis Stock CRON Trades Near 52-Week High: How to Play
Tipranks
Cronos Group Terminates VP Lloyd Wilson for Cause
Tipranks
Cronos Group’s Earnings Call Highlights Growth and Expansion
Tipranks
Trump Trade: Nvidia, AMD said to pay U.S. cut from China chip sales
SYNDTGAM
Cannabis stocks spike as Trump signals possible reclassification
FILE — Cured cannabis buds are displayed at Grassroots Vermont, a medicinal cannabis production facility, Dec. 7, 2018, in Brandon, Vt. Vermont has started taking prequalification applications from potential marijuana growers and retailers as it prepares for a retail market to open this fall of 2022. (Robert Layman/Rutland Herald via AP, File)
Tipranks
Cronos Group Appoints New Principal Accounting Officer
GlobeNewswire
Cronos Group Reports 2025 Second Quarter Results
Tipranks
Cronos Group (CRON) Gets a Buy from Roth MKM
Newswire.ca
High Tide Closes on $30 Million Convertible Debt from Cronos Group Inc.

Profile

Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as PharmaCan Capital Corp., is headquartered in Toronto, Canada.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.